North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520 Billion in 2016, at a CAGR of 6.5% during forecast period. Major factors contributing to growth of this market include rising prevalence of chronic diseases, growth in biologics market, funding initiatives for drug delivery research, and technological advancements. However, risk of needle stick injuries and side effects related to drugs are expected to restrain growth of this market in coming years.
- Agency -.
Complete details on North American Drug Delivery Technologies Market spread across 268 Pages, Profiling 11 Companies and Supported with 206 Tables and 57 Figures is now available at www.rnrmarketresearch.com/north-am…arket-report.html
North American drug delivery technologies market segmented into U.S. and Canada. U.S. is expected to continue to dominate market during forecast period.
Large share of U.S. in the North American market can primarily be attributed to factors such as rising prevalence of chronic diseases; rapid growth in geriatric population; growth in biologics market; and increasing number of regulatory approvals, new product launches, and technological advancements.
Company Profiles (Introduction, Products & Services, Strategy, & Analyst Insights, Developments)
1 Johnson & Johnson Services, Inc.
- Agency -.
2 Novartis AG
3 F. Hoffmann-La Roche Ltd.
4 Pfizer, Inc.
5 Bayer AG
6 Antares Pharma, Inc.
7 Becton, Dickinson and Company
8 Glaxosmithkline PLC
9 3M Company
10 Merck & Co., Inc.
The drug delivery technologies market company profiles comprise basic views on key players and their product portfolios, developments, and growth strategies adopted. The above mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographic focus and change in strategic approach, R&D investments, and levels of output in order to remain successful.
U.S. is expected to command largest share of North American drug delivery technologies market. Large share of U.S. in this market can primarily be attributed to factors like rapidly growing geriatric population; growth in biologics market; increasing number of regulatory approvals and new product launches; and growing number of workshops, conferences, and symposia being conducted in country.
2 Market Evolution Framework
3 Market Share Analysis
4 Competitive Situations and Trends
5 New Product Launches and Product Approvals
6 Partnerships, Agreements, and Collaborations
9 Other Strategies
Solid oral drug delivery is segmented into tablets, capsules, pills, and powders. In 2016, tablets are estimated to account for the largest share of the solid oral drug delivery market.
High patient compliance and acceptability are the major factors driving the growth of this market segment.
Topical drug delivery is segmented into solid, liquid, semi-solid, and transdermal drug delivery. Transdermal drug delivery is expected to register highest CAGR during forecast period.
Noninvasive nature of this drug delivery system, feasibility of self-administration, and improved patient compliance are major factors driving growth of transdermal drug delivery market.
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: